Skip to content
DraconiticResearch
Search Sources API
220,595 studies31 sourcesUpdated 27 min ago
Peer-reviewedCC BY-NC-NDJAMA Network Open

Testing the 40% to 60% Influenza Vaccine Effectiveness Heuristic

  • Matthew D. Wolpert1,2
  • Yuanyuan Liang3
  • Meagan C. Fitzpatrick2
  • Justin R. Ortiz2,4
4 affiliations
  1. 1Internal Medicine Residency Program, University of Maryland Medical Center, Baltimore
  2. 2Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore
  3. 3Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore
  4. 4Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Maryland School of Medicine, Baltimore
Read full textDOICite

Abstract

This meta-analysis evaluates the whether the 40% to 60% heuristic applied to estimates of influenza vaccine effectiveness accurately reflects performance across 20 years of US seasonal conditions.

Related

  1. An LLM enabled real-time estimation of seasonal influenza vaccine effectiveness from social media data
    M. J. Pavia, I. F. Amaro, D. Xu +2
    medRxivPreprintCC BY-NC-NDFull textEpidemiology & public healthmedRxiv
  2. Cost-effectiveness of recombinant influenza vaccine compared with standard-dose influenza vaccine among adults 50 years of age and older in Hong Kong
    Shuyi Zhong, Irene O. L. Wong, Peng Wu +1
    Human Vaccines & ImmunotherapeuticsPeer-reviewedCC BY-NC 4.0Full textEpidemiology & public healthPMC
  3. 2025/26 subclade-specific influenza A and B vaccine effectiveness estimates and discordant laboratory-based indicators of vaccine match or mismatch
    L. Separovic, S. E. Kaweski, M. B. Cox +17
    medRxivPreprintCC BY-NC-NDFull textEpidemiology & public healthmedRxiv
  4. Pediatric Influenza Vaccine Effectiveness Against Emergency Visits and Hospitalization in Canada: 2024-2025 and 2025-2026 seasons
    J. C. Kwong, D. M. Goldfarb, M. Bhatt +21
    medRxivPreprintCC BY-NC-NDFull textObstetrics, gynaecology & paediatricsmedRxiv
  5. Establishing a human co-infection challenge study of Streptococcus pneumoniae (Spn) and live attenuated influenza vaccine (LAIV) in older healthy adults: E xploring C o-infection with L ive Attenuated I nfluenza Vaccine and P neumococcu S in healthy old E r adults (ECLIPSE), a UK-based single-centre, single-blind randomised controlled trial
    Rebecca I Jackson, Oisin Hennigan, Karen Kelleher +20
    BMJ OpenPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossref

Cite

BibTeXRIS
BibTeX
@article{wolpert2026testing,
  title = {{Testing the 40% to 60% Influenza Vaccine Effectiveness Heuristic}},
  author = {Matthew D. Wolpert and Yuanyuan Liang and Meagan C. Fitzpatrick and Justin R. Ortiz},
  journal = {JAMA Network Open},
  year = {2026},
  month = nov,
  doi = {10.1001/jamanetworkopen.2026.42906},
  url = {https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2856370},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Testing the 40% to 60% Influenza Vaccine Effectiveness Heuristic
AU  - Matthew D. Wolpert
AU  - Yuanyuan Liang
AU  - Meagan C. Fitzpatrick
AU  - Justin R. Ortiz
PY  - 2026
DA  - 2026/11/02
JO  - JAMA Network Open
DO  - 10.1001/jamanetworkopen.2026.42906
UR  - https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2856370
AB  - This meta-analysis evaluates the whether the 40% to 60% heuristic applied to estimates of influenza vaccine effectiveness accurately reflects performance across 20 years of US seasonal conditions.
SN  - 2574-3805
ER  -